IMCR logo

Immunocore Holdings (IMCR) Cash From Operations

Annual CFO

$3.66 M
+$64.60 M+106.00%

December 31, 2023


Summary


Performance

IMCR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMCRcash flowmetrics:

Quarterly CFO

$21.13 M
-$2.35 M-9.99%

September 30, 2024


Summary


Performance

IMCR Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMCRcash flowmetrics:

TTM CFO

$22.28 M
+$11.04 M+98.19%

September 30, 2024


Summary


Performance

IMCR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIMCRcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IMCR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+106.0%+219.1%+657.8%
3 y3 years+104.7%+181.1%+116.1%
5 y5 years+116.5%+181.1%+116.1%

IMCR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+101.9%-10.0%+152.2%at high+115.1%
5 y5-yearat high+101.9%-10.0%+146.6%at high+115.1%
alltimeall timeat high+101.9%-10.0%+146.6%at high+115.1%

Immunocore Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$21.13 M(-10.0%)
$22.28 M(+98.2%)
Jun 2024
-
$23.47 M(-611.7%)
$11.24 M(-192.2%)
Mar 2024
-
-$4.59 M(-74.1%)
-$12.19 M(-514.5%)
Dec 2023
$3.66 M(-106.0%)
-$17.73 M(-275.8%)
$2.94 M(-58.7%)
Sep 2023
-
$10.09 M(>+9900.0%)
$7.11 M(-28.2%)
Jun 2023
-
$45.00 K(-99.6%)
$9.91 M(+441.0%)
Mar 2023
-
$10.54 M(-177.7%)
$1.83 M(-103.7%)
Dec 2022
-$60.94 M
-$13.56 M(-205.2%)
-$49.21 M(-31.3%)
Sep 2022
-
$12.89 M(-260.4%)
-$71.64 M(-35.2%)
Jun 2022
-
-$8.03 M(-80.2%)
-$110.57 M(-25.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$40.50 M(+12.5%)
-$147.90 M(+3.3%)
Dec 2021
-$196.88 M(+150.4%)
-$35.99 M(+38.2%)
-$143.11 M(+3.5%)
Sep 2021
-
-$26.05 M(-42.6%)
-$138.27 M(+20.7%)
Jun 2021
-
-$45.36 M(+27.0%)
-$114.51 M(+40.6%)
Mar 2021
-
-$35.71 M(+14.6%)
-$81.43 M(-2.4%)
Dec 2020
-$78.61 M(-40.2%)
-$31.15 M(+1258.9%)
-$83.47 M(+59.5%)
Sep 2020
-
-$2.29 M(-81.3%)
-$52.32 M(+4.6%)
Jun 2020
-
-$12.28 M(-67.5%)
-$50.03 M(+32.5%)
Mar 2020
-
-$37.75 M
-$37.75 M
Dec 2019
-$131.39 M(+492.3%)
-
-
Dec 2018
-$22.18 M
-
-

FAQ

  • What is Immunocore Holdings annual cash flow from operations?
  • What is the all time high annual CFO for Immunocore Holdings?
  • What is Immunocore Holdings annual CFO year-on-year change?
  • What is Immunocore Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Immunocore Holdings?
  • What is Immunocore Holdings quarterly CFO year-on-year change?
  • What is Immunocore Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for Immunocore Holdings?
  • What is Immunocore Holdings TTM CFO year-on-year change?

What is Immunocore Holdings annual cash flow from operations?

The current annual CFO of IMCR is $3.66 M

What is the all time high annual CFO for Immunocore Holdings?

Immunocore Holdings all-time high annual cash flow from operations is $3.66 M

What is Immunocore Holdings annual CFO year-on-year change?

Over the past year, IMCR annual cash flow from operations has changed by +$64.60 M (+106.00%)

What is Immunocore Holdings quarterly cash flow from operations?

The current quarterly CFO of IMCR is $21.13 M

What is the all time high quarterly CFO for Immunocore Holdings?

Immunocore Holdings all-time high quarterly cash flow from operations is $23.47 M

What is Immunocore Holdings quarterly CFO year-on-year change?

Over the past year, IMCR quarterly cash flow from operations has changed by +$38.86 M (+219.14%)

What is Immunocore Holdings TTM cash flow from operations?

The current TTM CFO of IMCR is $22.28 M

What is the all time high TTM CFO for Immunocore Holdings?

Immunocore Holdings all-time high TTM cash flow from operations is $22.28 M

What is Immunocore Holdings TTM CFO year-on-year change?

Over the past year, IMCR TTM cash flow from operations has changed by +$19.34 M (+657.79%)